Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jon D. van der Walt
Hydroxyurea Compared With Anagrelide in High-Risk Essential Thrombocythemia
New England Journal of Medicine
Medicine
Related publications
The Use of Anagrelide in Myeloproliferative Neoplasms, With Focus on Essential Thrombocythemia
Current Hematologic Malignancy Reports
Cancer Research
Oncology
Hematology
Takotsubo Cardiomyopathy in a Patient With Essential Thrombocythemia Treated With Anagrelide: Case Report
Cor et Vasa
Cardiovascular Medicine
Cardiology
Impact of Hydroxyurea on Survival and Risk of Thrombosis Among Older Patients With Essential Thrombocythemia
Journal of the National Comprehensive Cancer Network : JNCCN
Medicine
Oncology
Prinzmetal Angina in a Young Patient With Essential Thrombocythemia, After Anagrelide Initiation - Case Report and Literature Review
ARS Medica Tomitana
Biochemistry
Medicine
Genetics
Molecular Biology
Essential Thrombocythemia
New England Journal of Medicine
Medicine
Essential Thrombocythemia
Orphanet Journal of Rare Diseases
Medicine
Genetics
Pharmacology
Decreased Survival and Increased Rate of Fibrotic Progression in Essential Thrombocythemia Chronicled After the FDA Approval Date of Anagrelide
American Journal of Hematology
Hematology
ASXL1 Mutations in Chinese Patients With Essential Thrombocythemia
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
Efficacy and Safety of Anagrelide as a First‐line Drug in Cytoreductive Treatment‐naïve Essential Thrombocythemia Patients in a Real‐world Setting
European Journal of Haematology
Medicine
Hematology